Pune, India, December 2017 /MRFR Press Release/- Market Research Future published a cooked research report on global bilirubin blood test market.
Bilirubin is produced in the body when hemoglobin in old red platelets is broken down. This can be an indication of jaundice. Symptoms of jaundice include a yellowish shade of the skin, eyes, and certain body liquids. Bilirubin blood test is the process of measuring the amount of bilirubin in a blood sample, thereby, it is used in the diagnostics of jaundice. High prevalence of neonatal jaundice and increasing per capita healthcare expenditure is projected to drive the market growth during the forecast market. According to the Centers for Disease Control and Prevention in 2015, approximately 60% of full-term infants develop jaundice within several days of birth. Moreover, in 2015, according to the Centers for Disease Control and Prevention, in the U.S. the total healthcare expenditure accounted for 17.8% of the total gross domestic product (GDP), which accounted for USD 3.2 trillion. However, lack of awareness and trained professionals is likely to restrain the market growth during the review period
The global bilirubin blood test market is expected to grow at an approximate CAGR of 5.44% during the forecast period.
The global bilirubin blood test market is segmented on the basis of test type, product type, application, and end users.
On the basis of the test type, the market is segmented into indirect/unconjugated bilirubin test, direct/conjugated bilirubin test, and total serum bilirubin (TSB).
On the basis of the product type, the market is categorized into analyzers, bilirubinometer, and consumable. The analyzers segment is sub-segmented into the photometric analyzer, blood gas analyzer. The bilirubinometer segment is sub-segmented into hand-held, and bench top.
On the basis of the application, the market is segmented into pediatric/Infants and adults.
On the basis of the end users, the market is segmented into hospitals, pediatric clinics, and home healthcare.
North America dominates the bilirubin blood test market owing to a well-developed healthcare sector and rising healthcare expenditures. Moreover, the high prevalence of neonatal jaundice and developed economies like the U.S. and Canada fuel the market growth within the region. Additionally, the presence of the global players like Beckman Coulter, Inc., and Thermo Fisher Scientific Inc. within the regional boundaries of the North America provides favorable backgrounds for market growth.
Europe is the second largest bilirubin blood test market, which is followed by Asia Pacific. Availability of funds for research, well-developed healthcare infrastructure, huge patient population, and government support for research & development are likely to drive the market in the Europe.
Asia Pacific is the fastest growing region in the market. The presence of developing economies like India and China within the region, which have rising healthcare expenditures drives the market growth within the region. Moreover, favorable government policies and the presence of huge opportunities for the untapped market within the region boost the market growth.
Koninklijke Philips N.V. (Europe), Beckman Coulter, Inc. (Danaher) (U.S.), Thermo Fisher Scientific Inc. (U.S.), Randox Laboratories Ltd. (Europe), and F. Hoffmann-La Roche AG (Europe).